NCT04074590 - Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 3, 2020

Primary Completion Date

November 7, 2022

Study Completion Date

November 7, 2022

Conditions

Colitis, Ulcerative

Interventions

DRUG

LYS006

capsule for oral use

DRUG

Placebo

capsule for oral use

Trial Locations (9)

Novartis Investigative Site, Sofia

Novartis Investigative Site, Berlin

Novartis Investigative Site, Prague

Novartis Investigative Site, Novosibirsk

Novartis Investigative Site, Zlín

Novartis Investigative Site, Nowy Targ

Novartis Investigative Site, Warsaw

Novartis Investigative Site, Poznan

Novartis Investigative Site, Košice